Artikkelen redegjør innledningsvis for opprettelsen av statsøkonomisk eksamen i 1905 - den viktigste begivenhet i økonomifagets utvikling ved universitetet i de første 100 år av dets historie - og behandler deretter begivenheter som utspilte seg i 1910-20. I 1910 ble det for annen gang i...

Thorstein Veblen, a founder of original or old institutional economics, combined social and evolutionary thought in his institutionalist approach to dealing with psychological, social, and economic issues. The psychological content of Veblen's writings takes instinct and habits into...

This paper clarifies a common misrepresentation of our theory of capital as power, or CasP. Many observers tend to box CasP as an "institutionalist" theory, tracing its central process of "differential accumulation" to Thorstein Veblen's notion of "differential advantage". This view, we argue,...

This paper clarifies a common misrepresentation of our theory of capital as power, or CasP. Many observers tend to box CasP as an ‘institutionalist’ theory, tracing its central process of ‘differential accumulation’ to Thorstein Veblen’s notion of ‘differential advantage’. This...

This paper clarifies a common misrepresentation of our theory of capital as power, or CasP. Many observers tend to box CasP as an "institutionalist" theory, tracing its central process of "differential accumulation" to Thorstein Veblen's notion of "differential advantage". This view, we argue,...

Marxists love to hate the theory of capital as power, or CasP for short. And they have two good reasons. First, CasP criticizes the logical and empirical validity of the labour theory of value on which Marxism rests. And second, it offers the young at heart a radical, non-Marxist alternative...

In a recent article, Nicolas D. Villarreal claims that our empirical analysis of the relation between business power and industrial sabotage in the United States is unpersuasive, if not deliberately misleading. Specifically, he argues that we cherry-pick specific data definitions and smoothing...

Capitalizing a Cure takes readers into the struggle over a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When curative treatments for hepatitis C launched in 2013, sticker shock over their prices intensified the global debate over access...